Short-contact clobetasol propionate shampoo 0.05% improves quality of life in patients with scalp psoriasis.

Author(s): Tan J, Thomas R, Wang B, Gratton D, Vender R, Kerrouche N, Villemagne H, CalePso Study Team

Affiliation(s): Windsor Clinical Research Inc, 2224 Walker Rd, Suite 300, Windsor, ON N8W 5L7, Canada. jerrytan@bellnet.ca

Publication date & source: 2009-03, Cutis., 83(3):157-64.

Publication type: Historical Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

Scalp psoriasis has a considerable impact on the quality of life (QOL) of patients, and most patients are dissatisfied with available treatments. Clobetasol propionate shampoo 0.05% has been shown to be effective and safe for moderate to severe scalp psoriasis. We evaluated the effect of clobetasol propionate shampoo on QOL and the degree of participant satisfaction with the product. Participants received once-daily treatment for up to 4 weeks. Their QOL and degree of satisfaction were evaluated by questionnaires. The mean (standard deviation) Dermatology Life Quality Index (DLQI) score decreased significantly from 7.0 (4.9) at baseline to 3.2 (3.2) at week 4 (P<.001). Participants who considered the disease as having a small effect or no effect on their QOL increased from 45.6% at baseline to 81.7% at week 4. Most participants were satisfied with the cosmetic acceptability and the efficacy and safety aspects of the product, considered it better than prior treatments, and would use it again in the future. Therefore, we conclude that treatment with clobetasol propionate shampoo improved the QOL of participants and resulted in high satisfaction.